youtube_live
Inntekt Q3 2026 • utgitt • EPS overgikk forventningene +8,62% • Inntektene overgikk forventningene +2,31%
Se resultatenechevron_right
EW:NYSE
Edwards Lifesciences Corp
102,14 USD
arrow_upward
+1,31%(+1,32) 1 D
102,14 USD
0,00% (0,00)
bedtimeEtter stengetid
Stengt: 6. nov., 16:00:04 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EW …
Åpne
99,00 USD
Høy
102,19 USD
Lav
98,50 USD
Markedsverdi
58,87 mrd.
Snittvolum
4,32 mill.
Volum
5,11 mill.
P/E-forhold
57,91
52 u høy
104,16 USD
52 u lav
74,66 USD
EPS
1,76 USD
Beta
0,85
Utestående aksjer
575,00 mill.
Antall ansatte
16k
Åpne
99,00 USD
Høy
102,19 USD
Lav
98,50 USD
Markedsverdi
58,87 mrd.
Snittvolum
4,32 mill.
Volum
5,11 mill.
P/E-forhold
57,91
52 u høy
104,16 USD
52 u lav
74,66 USD
EPS
1,76 USD
Beta
0,85
Utestående aksjer
575,00 mill.
Antall ansatte
16k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Yahoo Finance
·
for 1 døgn siden
Edwards Lifesciences Q3 Earnings Call Highlights
News Corp
·
for 2 døgn siden
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Zacks
·
for 2 døgn siden
HIMS' Q3 Earnings: Can Weight Loss Momentum Drive Performance?
TradingView
·
for 2 døgn siden
Key facts: EW beats, lifts view; TAVR meets goals; stock hits 2022 high
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Om Edwards Lifesciences Corp
Administrerende direktør-
Ansatte16k
Grunnlagt1958
HovedkontorIrvine, California, USA
SektorHealth Care
Bransje-
Nettstededwards.com